Published in Haemostasis on January 01, 1981
A direct protective effect of sulphinpyrazone on ischaemic and reperfused rat hearts. Br J Pharmacol (1984) 0.80
A serial study of platelet reactivity throughout the first six months after myocardial infarction: its modification by sulphinpyrazone. Postgrad Med J (1987) 0.75
High mortality among recipients of bought living-unrelated donor kidneys. Lancet (1990) 4.25
Large scale identification of genes involved in cell surface biosynthesis and architecture in Saccharomyces cerevisiae. Genetics (1997) 2.81
Oxidation phenotype--a major determinant of metoprolol metabolism and response. N Engl J Med (1982) 2.72
The cause of hepatic accumulation of fructose 1-phosphate on fructose loading. Biochem J (1970) 2.71
Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine. Br J Clin Pharmacol (1975) 2.49
Metformin kinetics in healthy subjects and in patients with diabetes mellitus. Br J Clin Pharmacol (1981) 2.38
Dangers of intravenous fructose. Lancet (1972) 2.15
Inhibition of oxidative drug metabolism by beta-adrenoceptor antagonists in related to their lipid solubility. Br J Clin Pharmacol (1981) 2.08
Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet (1974) 1.97
Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy (2005) 1.70
Percutaneous nephrostomy insertion: outcome data from a prospective multi-operator study at a UK training centre. Clin Radiol (2004) 1.65
Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies. Br J Clin Pharmacol (1985) 1.64
The Capgras syndrome following head injury. Br J Psychiatry (1971) 1.63
The effects of catabolic and anabolic steroids on amino acid incorporation by skeletal-muscle ribosomes. Biochem J (1968) 1.57
Pain vs comfort scores after Caesarean section: a randomized trial. Br J Anaesth (2013) 1.57
Lactate production in the perfused rat liver. Biochem J (1971) 1.54
Lack of effect of atenolol on antipyrine clearance. Br J Clin Pharmacol (1982) 1.51
Barentsz is essential for the posterior localization of oskar mRNA and colocalizes with it to the posterior pole. J Cell Biol (2001) 1.50
celB, a gene coding for a bifunctional cellulase from the extreme thermophile "Caldocellum saccharolyticum". Appl Environ Microbiol (1990) 1.50
Spatial processing in the brain: the activity of hippocampal place cells. Annu Rev Neurosci (2001) 1.44
Outcome following saphenopopliteal surgery: a prospective observational study. Phlebology (2010) 1.43
Biochemical changes in skin and muscle after thermal injury. Br J Exp Pathol (1970) 1.42
Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy (2004) 1.40
Cimetidine: prophylaxis against upper gastrointestinal haemorrhage after renal transplantation. Br Med J (1978) 1.39
Two tRNA gene clusters associated with rRNA operons rrnD and rrnE in Bacillus subtilis. J Bacteriol (1993) 1.39
Nucleotide sequence of a gene from Caldocellum saccharolyticum encoding for exocellulase and endocellulase activity. Nucleic Acids Res (1989) 1.38
Proceedings: An isolated perfused rat brain--some histological and metabolic features. Clin Sci Mol Med (1974) 1.38
Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes. J Pharmacol Exp Ther (1988) 1.37
Lactic acidosis revisited. Diabetes (1983) 1.36
Intermittent claudication: factors determining outcome. Br Med J (1978) 1.33
Metoprolol and debrisoquin metabolism in Nigerians: lack of evidence for polymorphic oxidation. Clin Pharmacol Ther (1986) 1.32
Intracellular enzymes and protein synthesis in rabbit skin after thermal injury. Br J Pharmacol (1971) 1.31
Inhibition of 5-hydroxytryptamine-induced human blood platelet aggregation by chlorpromazine and its metabolites. Br J Pharmacol (1975) 1.31
Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indices. Br J Clin Pharmacol (1986) 1.29
Prenatal choline exposure alters hippocampal responsiveness to cholinergic stimulation in adulthood. Brain Res Dev Brain Res (2000) 1.28
Lignocaine and indocyanine green kinetics in patients following myocardial infarction. Br J Clin Pharmacol (1980) 1.28
Abnormally thin glomerular basement membranes associated with hematuria, proteinuria or renal failure in adults. Am J Nephrol (1985) 1.27
Letter: Factors influencing effect of hydrocortisone on rat brain tryptophan metabolism. Nature (1975) 1.27
The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6). Biochem Pharmacol (1994) 1.24
The changing face of emphysematous cholecystitis. Br J Radiol (1997) 1.23
The effect of heparin on the inositol 1,4,5-trisphosphate receptor in rat liver microsomes. Dependence on sulphate content and chain length. FEBS Lett (1989) 1.23
Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers. Clin Pharmacol Ther (1983) 1.22
A single emm gene-specific oligonucleotide probe does not recognise all members of the Streptococcus pyogenes M type 1. FEMS Microbiol Lett (1995) 1.21
Zebrafish: bridging the gap between development and disease. Hum Mol Genet (2000) 1.19
Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure. Lancet (1980) 1.18
Frequency of arrhythmias and other cardiac abnormalities in fulminant hepatic failure. Br Heart J (1976) 1.17
A histone-like protein (HTa) from Thermoplasma acidophilum. II. Complete amino acid sequence. J Biol Chem (1981) 1.15
Rapid mitochondrial enlargement in muscle as a response to triamcinolone acetonide and its relationship to the ribosomal defect. Biochem Pharmacol (1971) 1.14
Nitric oxide-induced mobilization of intracellular calcium via the cyclic ADP-ribose signaling pathway. J Biol Chem (1996) 1.14
Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan. Br J Clin Pharmacol (1980) 1.11
Lactic acidosis during metformin treatment in an elderly diabetic patient with impaired renal function. Acta Med Scand (1981) 1.11
Pulmonary artery banding: analysis of a 25-year experience. Ann Thorac Surg (1989) 1.09
Altered plasma drug binding in cancer: role of alpha 1-acid glycoprotein and albumin. Clin Pharmacol Ther (1982) 1.08
Effect of dietary supplementation with fish oil on systolic blood pressure in mild essential hypertension. Br Med J (Clin Res Ed) (1986) 1.08
Polymorphic metabolism of beta-adrenoceptor antagonists. Br J Clin Pharmacol (1984) 1.08
Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics. Br J Clin Pharmacol (1985) 1.07
Physicochemical properties, development, and regulation of central and peripheral monoamine oxidase activity. Adv Biochem Psychopharmacol (1974) 1.07
Lower moiety pelvic-ureteric junction obstruction (PUJO) of the duplex kidney presenting with pyonephrosis in adults. Br J Radiol (2003) 1.06
Ges, A human GTPase of the Rad/Gem/Kir family, promotes endothelial cell sprouting and cytoskeleton reorganization. J Cell Biol (2000) 1.06
Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1989) 1.06
The effect of glycerol and dihydroxyacetone on hepatic adenine nucleotides. Biochem J (1973) 1.05
A family study and the natural history of prenatally detected unilateral multicystic dysplastic kidney. J Urol (2002) 1.05
Some biochemical effects of triamcinolone acetonide on rat liver and muscle. Biochem J (1970) 1.03
Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaine. Br J Clin Pharmacol (1984) 1.03
Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol (1977) 1.02
The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations. Clin Pharmacokinet (1986) 1.00
Prolongation of rat tail bleeding time caused by oral doses of a thromboxane synthetase inhibitor which have little effect on platelet aggregation. Thromb Haemost (1982) 1.00
Testing for bimodality in frequency distributions of data suggesting polymorphisms of drug metabolism--hypothesis testing. Br J Clin Pharmacol (1989) 0.99
Testing for bimodality in frequency distributions of data suggesting polymorphisms of drug metabolism--histograms and probit plots. Br J Clin Pharmacol (1989) 0.99
Increased prevalence of activated CD70+CD4+ T cells in the periphery of patients with systemic lupus erythematosus. Lupus (2005) 0.98
The site at which 4-iodoacetamidosalicylate reacts with glutamate dehydrogenases. Biochem J (1973) 0.98
Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy. Lancet (1980) 0.98
Phylogeny of twenty Thermus isolates constructed from 16S rRNA gene sequence data. Int J Syst Bacteriol (1993) 0.98
A model of L(+)-lactate metabolism in normal man. Ann Nutr Metab (1982) 0.98
ProMAT calibrator: A tool for reducing experimental bias in antibody microarrays. J Proteome Res (2009) 0.98
Tryptophan metabolism in the isolated perfused liver of the rat: effects of tryptophan concentration, hydrocortisone and allopurinol on tryptophan pyrrolase activity and kynurenine formation. Br J Pharmacol (1976) 0.98
Determination of metformin in biological samples. Br J Clin Pharmacol (1978) 0.98
Bilateral massive ovarian edema: a case report. Ultrasound Obstet Gynecol (1998) 0.97
The amino acid sequence of the beta subunit of allophycocyanin. J Biol Chem (1981) 0.97
Fibrin, red cell and platelet interactions in an experimental model of thrombosis. Br J Pharmacol (1982) 0.96
A modified prognostic index based upon nutritional measurements. Clin Nutr (1982) 0.96
Backtracking booze with Bayes--the retrospective interpretation of blood alcohol data. Br J Clin Pharmacol (1991) 0.95
Complement activation and C1q binding activity in haemodialysis. Proc Eur Dial Transplant Assoc (1981) 0.95
The effect of modifying lysine-126 on the physical, catalytic and regulatory properties of bovine liver glutamate dehydrogenase. Biochem J (1973) 0.95
Effects of haemoperfusion through charcoal or XAD-2 resin on an animal model of fulminant liver failure. Gut (1974) 0.95
The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol. Br J Clin Pharmacol (1984) 0.94
Beta-blocker withdrawal syndrome. Lancet (1979) 0.94
A ribosomal fraction from cat skin. J Physiol (1968) 0.94
The relationship between cyclic adenosine 3', 5' - monophosphate and biochemical events in rat skin after the induction of epidermal hyperplasia using hexadecane. Br J Dermatol (1978) 0.93
Sequence and expression of a xylanase gene from the hyperthermophile Thermotoga sp. strain FjSS3-B.1 and characterization of the recombinant enzyme and its activity on kraft pulp. Appl Environ Microbiol (1995) 0.93
Fish oil modifies lipids and reduces platelet aggregability in haemodialysis patients. Nephron (1986) 0.93
Metabolism of an oral tryptophan load. II: Effect of pretreatment with the putative tryptophan pyrrolase inhibitors nicotinamide or allopurinol. Br J Clin Pharmacol (1980) 0.92
The amino acid sequence of fragment A, an enzymically active fragment of diphtheria toxin. II. The cyanogen bromide peptides. J Biol Chem (1979) 0.92
Changes in mitochondrial structure and ribosomal activity in muscle as a consequence of the interaction between a glucocorticoid and some anabolic steroids. Biochem J (1969) 0.92
The influence of tissue environment on the rates of metabolic processes and the properties of enzymes. Biochem Pharmacol (1975) 0.92